Clenergen Corp. is a biofuels company that is approaching the sector from a different perspective – from an agronomy/biology and plantation standpoint. The company’s goal is to produce high-density, short-rotation biomass crops on a commercial scale which will then be used to power, steam and perhaps produce other products from advanced gasification and steam technologies.

The company is led by an eminent Board of Directors and Advisors. Here is a brief overview of the members:

Dr. Arvind Pandalai – Non-Executive Group Chairman

Dr. Pandalai has 32 years of experience in international trading, export and import management, joint ventures, project and financial management along with strategic planning. He has numerous prestigious management awards in his native India.

Robert Kohn – Non-Executive Vice-Chairman, North America

Mr. Kohn has been chairman/CEO, president/COO, and co-founder of three start-up public companies, with a combined market cap of over $1.5 billion.

This month, we received word that the independent Hulbert Financial Digest just ranked our investment letter – The Oxford Club Communiqué – among the five top-performing letters in the nation over the past 10 years. Part of our success has come from knowing what to buy. Another major factor is knowing when to sell. And that, quite frankly, is the result of keeping our trailing stop discipline.

Whenever a recommended stock closes 25% below its closing high – or our original recommended price – we sell, no questions asked…

Why do we do this? Number one, a stock trader needs to have a sell discipline or he’s simply flying by the seat of his pants. Anyone can plunk for a few shares. But getting out at the right time is the true art of investing.

Your timing will never be perfect, of course. No investment

I recently had the privilege of interviewing Mr. Charles Nenner, president and founder of the Charles Nenner Research Center.  I have posted several articles here highlighting Mr. Nenner’s recent market predictions and even conducted an interview with David Gurwitz, Managing Director of the Charles Nenner Research Center but this is my first interview with Nenner himself.

In my 40 minute phone interview, Mr. Nenner discussed a wide range of topics.  Following are just a few of the topics covered:

1.  How cycles are calculated and how traders can best use these cycles to catch 6-8 week moves in the market.

2.  His explanation of a recent quote “I deal with what is going to happen and then I deal with why it is going to happen.”

3.  His “top down approach” to trading.

4.  His understanding

PennyOmega.com Stock Report!

PennyOmega.com Hot Stock News & Alerts!

Tuesday August 18, 2009

PennyOmega.com Stock Report!

**************************************************************

Provectus Pharmaceuticals, Inc. (OTCBB:PVCT), a development-stage oncology and dermatology biopharmaceutical company, has added Mount Sinai School of Medicine as its second and final site for its expanded Phase 2 clinical trial of the Company’s lead dermatology agent PH-10 for psoriasis. Jason Emer, M.D. will serve as principal investigator of the trial; he is also the lead investigator for the Phase 2 clinical trial of PH-10 for atopic dermatitis, for which patient enrollment was completed in June.

Consistent with its ongoing efforts to enhance services offered to its customers and contract services clients, SouthWest Water Company (NASDAQ:SWWC), a leading provider of

Denise Shull, President and Founder of Trader Psyches, focuses on helping traders think about thinking and in doing so I believe she offers a great deal of insight for serious traders.  She was recently interviewed on CNBC, so take a listen.

I have been attempting to conduct an interview with Ms Shull but due to her busy schedule I have been unable to do so thus far.  However,  I was able to get an answer to one question in an email exchange I had with her.  I asked Ms Shull whether or not successful traders are born or made.  Her answer: “they are

Despite the recessionary environment, demand for specialty coffee has been rising. According to the data provided by the National Coffee Association's (NCA) 2009 National Coffee Drinking Trends market research survey, coffee consumption has remained steady at 59% so far in 2009, and the NCA also stated that the at home consumption has hit the highest levels in 2009 since 2003 increasing by 5%.

Further, Andrew Hetzel, President and Founder of Cafemakers, states that, a smaller-sized coffee with strong flavors provides more satisfaction to the consumer and therefore customers are also willing to pay more. Customers choose specialty coffee brands based on the total value proposition that includes quality, variety, convenience, and price. Therefore, companies such as Green Mountain Coffee Roasters (GMCR), Peet's Coffee & Tea (PEET), Kraft Foods (KFT), Sara Lee (SLE)